Previous Article | Next Article 
Journal of Bacteriology, June 2000, p. 3063-3071, Vol. 182, No. 11
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Morphogenesis, Adhesive Properties, and Antifungal
Resistance Depend on the Pmt6 Protein Mannosyltransferase in the
Fungal Pathogen Candida albicans
Claudia
Timpel,1
Sigrid
Zink,2
Sabine
Strahl-Bolsinger,3
Klaus
Schröppel,4 and
Joachim
Ernst1,*
Institut für Mikrobiologie,
Biologisch-Medizinisches Forschungszentrum,1 and
Diabetes-Forschungsinstitut,
Heinrich-Heine-Universität,2 D-40225
Düsseldorf, Lehrstuhl für Zellbiologie und
Pflanzenphysiologie, Universität Regensburg,
Regensburg,3 and Institut für
Klinische Mikrobiologie, Immunologie und Hygiene, Universität
Erlangen, Erlangen,4 Germany
Received 22 December 1999/Accepted 8 March 2000
 |
ABSTRACT |
Protein mannosyltransferases (Pmt proteins) initiate O
glycosylation of secreted proteins in fungi. We have characterized PMT6, which encodes the second Pmt protein of the fungal
pathogen Candida albicans. The residues of Pmt6p are 21 and
42% identical to those of C. albicans Pmt1p and S. cerevisiae Pmt6p, respectively. Mutants lacking one or two
PMT6 alleles grow normally and contain normal Pmt enzymatic
activities in cell extracts but show phenotypes including a partial
block of hyphal formation (dimorphism) and a supersensitivity to
hygromycin B. The morphogenetic defect can be suppressed by
overproduction of known components of signaling pathways, including
Cek1p, Cph1p, Tpk2p, and Efg1p, suggesting a specific Pmt6p target
protein upstream of these components. Mutants lacking both
PMT1 and PMT6 are viable and show
pmt1 mutant phenotypes and an additional sensitivity to the
iron chelator ethylenediamine-di(o-hydroxyphenylacetic
acid). The lack of Pmt6p significantly reduces adherence to endothelial
cells and overall virulence in a mouse model of systemic infection. The
results suggest that Pmt6p regulates a more narrow subclass of proteins in C. albicans than Pmt1p, including secreted proteins
responsible for morphogenesis and antifungal sensitivities.
 |
INTRODUCTION |
Secreted proteins in fungi can get
modified by the attachment of short glycosyl chains consisting of one
to seven mannoses to serine or threonine residues (reviewed in
reference 38). The first mannosylation step in O
glycosylation occurs in the endoplasmic reticulum, presumably
cotranslationally, and is mediated by protein mannosyltransferases (Pmt
proteins). In the yeast Saccharomyces cerevisiae seven
PMT genes are known (20, 24, 28, 37); their
paralogous gene products, by their degree of homology, can be grouped
in at least two subclasses consisting of either the Pmt1 and Pmt5
proteins or the Pmt2, Pmt3, and Pmt6 proteins (10). We
recently isolated and characterized the PMT1 gene of the
important human fungal pathogen Candida albicans
(41). Pmt homologues in Drosophila melanogaster
(25) and humans (21) have also been described,
and Pmt homologues deduced from "expressed sequence tags" occur in
nematodes, plants, and mammals, although their enzymatic functions as
Pmt proteins have not yet been demonstrated. In C. albicans,
O-glycosyl chains initiated by Pmt proteins are extended
further by mannosyltransferases including Mnt1p (3).
Although the molecular details of target protein recognition by Pmt
proteins are unknown, it appears that Pmt proteins can have a
preference for certain glycosylation targets. Thus, the lack of Pmt1
and Pmt2 proteins in S. cerevisiae mutants affects O
glycosylation of a set of secreted proteins overlapping with, but
different from, the set affected in mutants lacking Pmt4p (16), and certain cell wall proteins are affected
differently by mutations in PMT genes (28).
Recently, the Axl2p protein, involved in axial budding, was recognized
as a specific target of mannosylation by Pmt4p (29). Unknown
O-glycosylated proteins are needed for general cell viability, since
S. cerevisiae pmt1 pmt2 double mutants show reduced growth
and some triple pmt mutants are not viable (15).
Likewise, the lack of both pmt1 alleles in C. albicans negatively affects growth (41). On the other hand, specific phenotypes have been observed in pmt mutants.
S. cerevisiae pmt1 mutants are partially resistant to K1
killer factor (24) and are unable to grow anaerobically in
minimal medium (2). C. albicans pmt1/pmt1
homozygous and PMT1/pmt1 heterozygous strains showed an
increased sensitivity to aminoglycoside antibiotics and a defect in
hyphal morphogenesis (41). A cellular differentiation defect
was also observed in Drosophila strains lacking the PMT gene
homologue rotated abdomen (25).
Here we describe a second PMT gene of C. albicans, PMT6, which encodes a Pmt protein highly
homologous to S. cerevisiae Pmt6p and thus is a
representative of the second subgroup of S. cerevisiae proteins. We demonstrate that deletion of PMT6 does not
affect growth in general but rather generates specific phenotypes, such as antifungal supersensitivity and defective filamentation. Suppression experiments strongly suggest that O glycosylation by Pmt6p affects a
specific component upstream of known signaling cascades, triggering morphogenesis. Defects in properties of adhesion to target cells and
the reduced virulence of pmt6 mutants demonstrate the
importance of Pmt6p for cellular differentiation and virulence of
C. albicans.
 |
MATERIALS AND METHODS |
Strains and media.
The C. albicans
strains and the plasmids are listed in Table
1. C. albicans strains CAI4
(11) and CAP1-3121 (41) were used for
transformations and gene disruptions. Strains were grown in yeast
extract-peptone-dextrose (YPD) or SD medium (34), which for
Ura
strains was supplemented with 20 µg of uridine/ml.
Transformations were performed using the spheroplast method
(34). Hyphae were induced on solid "Spider" medium
(22) or in liquid using serum (9) or 2.5 mM
GlcNAc (18) as the inducer.
Sequencing of PMT6 and plasmid constructions.
A
plasmid containing PMT6 was identified in the C. albicans genome project (p99) (S. Scherer, personal communication;
http://www-sequence.stanford.edu/group/candida). Subfragments of p99
were ligated into pUC19 and sequenced from both ends using M13 forward
(U-40) and reverse primers or by using insert-specific
oligonucleotides. The 5.3-kb HindIII fragment containing
PMT6 of p99 was inserted into the HindIII
site of pRC18 (36) to generate replicating plasmids (pCT34
and pCT35 with inverse insert orientation).
Disruption of PMT6.
For disruption of the C. albicans PMT6 gene, plasmid pCT17 was cut with Asp718
and PstI and the 4.0-kb "Ura blaster" fragment (cut with
Asp718 and PstI) from p5921 (17) was
ligated into this vector. From the resulting plasmid, pCT25, a 5.7-kb
XhoI fragment (Fig. 1A) was isolated and used for
transformation of strains CAI4 and CAP1-3121. Correct insertion of this
fragment into one of the two PMT6 alleles was verified by
Southern blotting of DNA of transformants, which was cut with
BglII and HindIII and probed with a 1.1-kb
NcoI-SalI fragment derived from the
PMT6 promoter region (Fig. 1A). One of the strains
generated, e.g., CAP2-2, with the genotype
pmt6
::hisG-URA3-hisG/PMT6,
was plated out on medium containing 0.02% 5-fluoroorotic acid (5-FOA)
(26). Spontaneous 5-FOA-resistant strains were analyzed for
loss of the URA3 sequence by Southern blotting. One of the
identified strains, CAP2-23, with the genotype
pmt6
::hisG/PMT6, was used for a
second round of gene disruption with the C. albicans pmt6 URA blaster fragment of pCT25. Several transformants had the genotype pmt6
::hisG/pmt6
::hisG-URA3-hisG,
and strain CAP2-239 was chosen to identify strains by 5-FOA resistance.
Strain CAP2-2391 is a representative of mutant strains with the
genotype
pmt6
::hisG/pmt6
::hisG. The PMT6 gene was reintroduced into CAP2-2391 by
transforming this strain with either plasmid pCT34 or pCT35 (Table 1).
Adherence to endothelial cells.
Porcine aortic endothelial
cells (PAEC) were isolated from aortas of freshly slaughtered pigs,
which were obtained from the local slaughterhouse. The lumina of the
aortas were washed with phosphate-buffered saline (PBS; 140 mM NaCl, 4 mM KCl, 1 mM Na2HPO4 · 2H2O,
1 mM KH2PO4, 12 mM glucose, pH 7.4) under
sterile conditions, and the adventitia was removed (43). The
remaining part was immersed completely in 30 ml of dispase solution
(0.5 mg/ml; Boehringer, Mannheim, Germany) for 15 min at 37°C in an
incubator. Afterwards the aortas were fixed on an aluminum tray and the
endothelial cells (EC) were scraped off with a rubber policeman. The
cells harvested by each scrape were plated in different wells of a
six-well dish (pretreated with 0.2% gelatin solution for 30 min at
room temperature). PAEC were cultured at 37°C in the humidified
atmosphere of an incubator at 5% CO2-95% air in M199
(Sigma, Munich, Germany) containing 10% fetal calf serum, 30 mM HEPES,
3 mM glutamine, 0.38 g of Dulbecco's PBS/liter, and 4 mg of
penicillin and streptomycin/liter. Subcultures were carried out by
detaching the cells with trypsin solution (0.5 mg/ml; Sigma), spinning
them down at 100 × g for 10 min, and plating them in a
dilution of 1:7 (approximately 15,000 cells/cm2). Cells
were identified as EC by their cobblestone morphology, the uptake of
1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbo-cyanine perchlorate-labeled acetylated low-density lipoprotein (Paesel, Frankfurt, Germany), and the immunostaining of factor VIII-related antigen.
Monolayers established in six-well plates were used 2 to 4 days after
confluency for adhesion assays. The adhesion of
C. albicans cells was determined as described previously (
41).
Animal experiments.
Virulence studies were performed as
described previously (6). Briefly, strains were harvested
from stationary cultures after growth in selective media, adjusted to
the desired density in PBS, and injected intravenously into the tail
vein in a final volume of 200 µl. The viability of the inoculum was
controlled by serial plating of the cells, and the actual infectious
load was adjusted accordingly after overnight storage of cells at
4°C. At the time of inoculation viable cell counts were checked again by plating to verify identical loads of infection. After infection, animals were examined for behavioral changes and changes of habit. Survival and mortality were monitored twice a day. Kaplan-Meyer survival graphs were plotted using the GraphPad Prism software, which
was also used for log rank test curve comparisons (Mantel-Haenszel test).
Other methods.
For RNA preparation cells were grown in YPD
to an optical density at 600 nm between 1.3 and 1.9 or they were
induced in 2.5 mM GlcNAc as described by Holmes and Shepherd
(18). Total RNA was prepared as described by Schmitt et al.
(33). RNA blotting was performed as described previously
using the 1.5-kb ClaI-SalI ACT1
fragment (9), a 1.5-kb BamHI-HincII
fragment carrying a portion of the PMT1 coding region
(41), and the 1.5-kb PstI-XhoI fragment of pCT17 carrying PMT6 as the probes.
The assay for enzymatic Pmt activity was performed as described
previously (
41). Although measurements of Pmt activity were
highly reproducible, the level of residual Pmt activity remaining
in
pmt1/pmt1 mutants was found to be variable and to depend
strongly
on the preparations of Dol-P-[
14C]Man and of the
acceptor
peptide.
Nucleotide sequence accession number.
PMT6 was
assigned accession no. AF104916 (GenBank/EMBL).
 |
RESULTS |
Sequence of PMT6.
A clone containing the whole
PMT6 gene (p99) was identified in the C. albicans
sequencing project (http://www-sequence.stanford.edu/group/candida). The sequence of PMT6 was determined using M13 standard
primers and sequence-specific oligonucleotides. It comprises an open
reading frame of 826 codons for a protein with a calculated molecular mass of 94 kDa. Two serine residues at positions 38 and 538 are encoded
by nonstandard CUG codons (31). The deduced Pmt6 protein and
the S. cerevisiae Pmt6 protein have 42% identical residues, whereas Pmt6p is only 21% identical to Pmt1p (41). The
identities to other S. cerevisiae Pmt proteins were much
lower; for this reason the gene was designated PMT6.
Recently, gene fragments encoding a conceptual Pmt4p homologue of
C. albicans were also identified in the C. albicans sequencing project. Sequence comparisons indicated that
Pmt6p is clearly different from Pmt4p (22% identity). Computer
analysis predicted that Pmt6p is an integral membrane protein, possibly
containing 10 transmembrane domains; 7 of these domains coincide with
transmembrane regions that have been determined experimentally in Pmt1p
of S. cerevisiae (39). Assuming a similar overall
structure, the highest degree of identity is present between transmembrane regions I and II and V and VI, respectively, which are
the regions constituting both large luminal loops. Pmt6p is also
predicted to contain a leucine zipper domain starting at position 723. Four asparagine residues represent potential N glycosylation sites at
positions 20, 59, 357, and 453.
Disruption of PMT6 alleles.
The Ura blaster
technique (11) was used to disrupt both alleles of
PMT6 in the C. albicans PMT1/PMT1 strain CAI4 and
the pmt1/pmt1 mutant strain CAP1-3121 (Table 1; Fig.
1A). Chromosomal DNA of transformants was
digested with BglII and HindIII and analyzed by Southern hybridization using a specific probe for the
PMT6 promoter. The wild-type PMT6 allele
displayed a 4.9-kb band (Fig. 1B and C, lane 1), whereas a 7.1-kb band
was observed in transformants with the Ura blaster integrated into one
allele of PMT6 (Fig. 1B and C, lane 2). After selection on
FOA medium, the loss of the URA3 gene and one copy of the
hisG element resulted in a 4.3-kb band (Fig. 1B and C, lane
3). The remaining intact PMT6 allele was disrupted
similarly, leading to homozygous
pmt6::hisG/pmt6
::hisG-URA3-hisG strains (Fig. 1B and C, lane 4) and corresponding Ura
derivatives (Fig. 1B and C, lane 5). Thus, these procedures generated strains lacking only PMT6 alleles or doubly mutated strains
lacking both PMT6 and PMT1 alleles. Phenotypes
reported below were observed in at least two disrupted or reconstituted
strains, which were independently isolated.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Sequential disruption of PMT6 alleles. (A)
Schematic representation of the construction of the different alleles.
The wild-type PMT6 gene and the PMT6 alleles
disrupted by the hisG-URA3-hisG cassette or by
hisG are shown. H, HindIII; N,
NcoI; X, XhoI, S, SalI; P,
PstI; B, BglII; A, Asp718. The
fragment marked by asterisks was used as a probe for Southern analysis.
(B and C) Southern blots of
HindIII-BglII-digested chromosomal DNA of the
following strains: SC5314 (PMT6/PMT6; lane 1 [B and C]);
CAP2-2
(PMT6/pmt6 ::hisG-URA3-hisG;
lane 2 [B]); CAP2-23
(PMT6/pmt6 ::hisG; lane 3 [B]); CAP2-239
(pmt6 ::hisG-URA3-hisG/pmt6 ::hisG;
lane 4 [B]); CAP2-2391
(pmt6 ::hisG/pmt6 ::hisG;
lane 5 [B]); CPP1
(PMT6/pmt6 ::hisG-URA3-hisG;
lane 2 [C]); CPP11
(PMT6/pmt6 ::hisG; lane 3 [C]); CPP117
(pmt6 ::hisG-URA3-hisG/pmt6 ::hisG;
lane 4 [C]); CPP1171
(pmt6 ::hisG/pmt6 ::hisG;
lane 5 [C]).
|
|
Supersensitivity of pmt6 mutants.
We previously
observed that homozygous pmt1 mutants showed increased
sensitivities to various antifungals (G418, hygromycin B, and
clotrimazole), calcofluor white, and sodium dodecyl sulfate (SDS)
(41). For that reason we also tested the susceptibilities of
heterozygous and homozygous pmt6 mutants (Fig.
2A), as well as those of double mutants
carrying pmt1 and pmt6 disruptions (Fig. 2B), to
various agents.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 2.
Sensitivities of C. albicans strains. The
wild-type strain SC5314 (PMT1/PMT1 PMT6/PMT6) was compared
with strain CAP2-2 (PMT1/PMT1 PMT6/pmt6), strains CAP2-234
and CAP2-2341 (PMT1/PMT1 pmt6/pmt6), strain CPP1
(pmt1/pmt1 PMT6/pmt6), and strains CPP117 and CPP1171
(pmt1/pmt1 pmt6/pmt6). Plasmid pCT34 carries
PMT6, and plasmid pCT30 carries PMT1. Strains
were grown on YPD medium without or with hygromycin B (200 µg/ml) or
on SD medium without or with EDDHA (300 µM). The plates were
incubated for 2 days at 30°C.
|
|
Strains carrying one or two
pmt6 mutant alleles grew well in
the presence of 100 µg of hygromycin B/ml, whereas they failed
to
grow at 200 µg/ml (Fig.
2A). Remarkably, the heterozygous
PMT6/pmt6 and the homozygous
pmt6/pmt6 mutant
showed the same phenotypes.
No increased sensitivities to nystatin (10 to 15 µg/ml), amphotericin
B (0.5 to 1.5 µg/ml), clotrimazole (1 to
2 µg/ml), fluconazole
(5 µg/ml), fluphenazine (50 µg/ml), SDS
(0.06%), calcofluor white
(10 to 25 µg/ml), G418 (0.8 to 1.2 mg/ml),
and sodium orthovanadate
(10 to 20 mM) were detected in
pmt6
disruptants.
C. albicans pmt1/pmt1 strains with disruptions
in at least one
PMT6 allele showed the
same phenotype with
regard to antifungals as
pmt1 mutants: supersensitivity
to
G418, SDS, calcofluor white, clotrimazole, and low concentrations
of
hygromycin B (
41). Furthermore, we could detect an increased
sensitivity of
pmt1 or
pmt1 pmt6 mutants to Congo
red (200 µg/ml),
which was not observed in
pmt6
disruptants (data not
shown).
Interestingly, the
pmt1 pmt6 mutants also showed new
phenotypes that were not detected in strains carrying homozygous single
mutations.
pmt1 and
pmt6 single disruptants were
resistant to
a 300 µM concentration of the iron chelating agent
ethylenediamine-di(
o-hydroxyphenylacetic
acid) (EDDHA), as
was the wild-type strain (SC5314). However,
the
pmt1/pmt1
pmt6/pmt6 double mutant (CPP117) and the
pmt1/pmt1 PMT6/pmt6 heterozygous strain (CPP1) were no longer able to grow
in the presence of 300 µM EDDHA (Fig.
2B). This new phenotype
was
completely suppressed by overexpression of
PMT1 (plasmid
pCT30).
In addition to EDDHA sensitivity, slightly reduced growth of
strains
CPP1 and CPP117 compared to that of singly mutated strains was
also observed on YPD medium containing 20 mM caffeine (data not
shown).
PMT6 is required for hyphal morphogenesis.
Hypha
formation is induced in certain media including Spider medium
(22) or in the presence of positive stimuli including serum
or N-acetylglucosamine (GlcNAc) (5). We reported
previously that pmt1 mutants are unable to develop hyphae on
Spider medium, while they still form hyphae if induced by serum or
GlcNAc (41). Therefore, the ability of pmt6
mutants to form hyphae was tested.
The heterozygous
PMT6/pmt6 strains, as well as the
homozygous
pmt6/pmt6 disruptants showed normal hyphal
formation during
induction by serum and GlcNAc (data not shown) but a
decreased
ability to form hyphae on Spider medium (Fig.
3A). Again, as for
hygromycin B
sensitivity (Fig.
2A), the heterozygous and the homozygous
pmt6 mutants showed identical defective phenotypes. A doubly
mutated
strain lacking both
PMT1 and
PMT6 alleles
was completely morphogenesis
negative on Spider medium (Fig.
3B), as
were
pmt1 single mutants
(
41). Reintroduction of
PMT6 into the
pmt6/pmt6 mutant restored
morphogenesis as expected; in addition,
PMT1 expression
complemented
the
pmt6 mutant phenotype, suggesting common
functions of Pmt6p
and Pmt1p. Pmt6p may have a more narrow substrate
specificity
than Pmt1p since
PMT6 overexpression did not
complement the
pmt1 phenotype (Fig.
3A).

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 3.
Hypha formation of C. albicans strains. Shown
are sections of colonies grown for 3 days on Spider medium at 37°C.
(A) Phenotypes of pmt single mutants. The indicated
pmt6/pmt6 strains were complemented with a plasmid carrying
PMT6 (pCT34) or PMT1 (pCT30); as controls a
pmt1/pmt1 strain complemented by PMT6 (pCT35) and
a wild-type strain (SC5314) were analyzed. (B) Phenotypes of
pmt double mutants. The indicated pmt1/pmt1
pmt6/pmt6 double mutants were transformed with plasmid pCT30
(PMT1) or pCT35 (PMT6). (C) Suppression of the
pmt6 phenotype by genes encoding signaling components.
Strain CAP2-2391 (pmt6/pmt6) was transformed with plasmids
carrying EFG1, CEK1, CPH1, or
TPK2 genes (Table 1). As a control, an efg1/efg1
mutant strain transformed with pCT35 (PMT6) was analyzed.
|
|
Because strains lacking one or two
PMT6 alleles had the same
defective phenotype, we speculated that only one allele of
PMT6 was functional, as in the natural heterozygosity of
some
C. albicans strains (
32), or that pairing of
alleles was required for expression
(
1). Alternatively, a
threshold level of Pmt6p was presumed
to be necessary for cells to
generate the wild-type morphogenetic
phenotype. To determine if
PMT6 is expressed in an allele-specific
manner, Northern
analyses were performed. All four independent
heterozygous
PMT6/pmt6 transformants contained a 3-kb
PMT6
transcript
(data not shown), suggesting that
PMT6 is not
expressed in such
a
manner.
Because of the effects of
PMT6 on morphogenesis, we tested
if
PMT6 expression depends on hyphal induction. For this
experiment
the
PMT strain CAI4(pRC2312) was induced by 2.5 mM GlcNAc according
to standard procedures (
9); at different
time points after
induction the percentage of hyphae was determined and
RNA was
isolated for Northern analysis (Fig.
4). The results demonstrate
that the
PMT6 transcript level is lowered slightly during the
first
50 min of induction, but decreases severalfold after this
time; thus,
hyphal morphogenesis and
PMT6 transcript levels are
not
closely correlated. Reprobing the same Northern blot with
PMT1 revealed that the
PMT1 transcript is also
not correlated
closely to the degree of hyphal development, since it
remains
relatively constant during the first 50 min of induction and
increases
only slightly after this time. Figure
4 allows a rough
estimation
of the relative amounts of both
PMT transcripts,
because probes
of similar lengths and specific activities were used.
The autoradiographic
exposure times were 4 days for
PMT1 and
9 days for
PMT6. Considering
that the
PMT1 signal
has about twice the strength of that of
PMT6 at 0 min, we
estimate that the level of the
PMT6 transcript is
about 25%
relative to the level of the
PMT1 transcript; this ratio
changes during hyphal formation further in favor of the
PMT1
transcript.
The downregulation of the
PMT6 transcript had a
different kinetics
from that of the downregulation of the
EFG1 transcript described
previously (
36),
because the latter transcript disappeared much
more rapidly during
hyphal induction. Furthermore, we could show
by Northern blottings that
high and low
EFG1 expression levels
in strain SS4 grown in
different media (
36) did not alter
PMT6 transcript levels, thus arguing against a close expressional
correlation
of both genes (data not shown).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 4.
PMT6 and PMT1 transcripts during
hyphal induction. The wild-type strain CAI4(pRC2312) was induced to
form hyphae in the presence of 2.5 mM GlcNAc. At the indicated times
the percentages of hypha-forming cells were determined and total RNA
was prepared and analyzed by Northern blotting using probes for the
indicated genes.
|
|
Suppression of pmt6 morphogenetic phenotypes.
Conceivably, the inability of pmt6/pmt6 and
PMT6/pmt6 strains to form hyphae was due to one of several
possibilities, including (i) defects in structural components required
for hyphal morphogenesis and (ii) defects in a component of signaling
pathways that translate environmental stimuli into alterations of the
cell form (e.g., an O-glycosylated membrane "sensor"). Because in
pmt6 mutants hyphal morphogenesis occurred in the presence
of serum or GlcNAc, the former hypothesis appeared unlikely. The
alternative hypothesis predicts that stimulation of components situated
downstream of Pmt6p targets would suppress the morphogenetic defects of
pmt6 mutants. To test this possibility, we transformed the
pmt6/pmt6 strain CAP2-2391 with plasmids allowing
overexpression of the mitogen-activated protein (MAP) kinase Cek1p and
its downstream transcription factor, Cph1p (7, 22), or with
plasmids allowing overexpression of the catalytic subunit of the
protein kinase A isoform (Tpk2p) (35) and of the
morphogenetic regulator Efg1p (36).
As shown in Fig.
3C overproduction of all tested components of
signaling pathways was able to relieve the morphogenetic block
of the
pmt6/pmt6 mutant, although to various degrees.
Overexpression
of genes encoding transcription factors Efg1p and Cph1p
showed
a strong complementation, similar to complementation by
PMT6 itself,
while overexpression of the genes encoding the
kinases Cek1p and
Tpk2p resulted in weaker restoration. The different
degrees of
suppression may be related to promoter strengths, because in
the
plasmids used
EFG1 and
CPH1 are controlled by
the strong
PCK1 and
ADH1 promoters, while the
CEK1 and
TPK2 genes are transcribed
by their
natural promoters. On the other hand, the complete block
of hyphal
formation in a
pmt1/pmt1 mutant or the partial block
of
morphogenesis in a
PMT1/pmt1 mutant could not be altered by
overexpression of the above signaling components (data not shown),
suggesting (i) that
pmt1 mutants contain defects unrelated
to
signaling and (ii) that residual morphogenesis was not responsible
for suppression of the
pmt6 morphogenetic defect. We point
out
that the antifungal sensitivities of the
pmt6 mutants
described
above could not be suppressed by any of the signaling
components
(data not shown), indicating that the functions of Pmt6p in
morphogenesis
and antifungal sensitivities are separable. These results
are
compatible with the hypothesis that the
pmt6
morphogenetic phenotype
is caused by defects in one or more specific
components which
function upstream of known signaling components,
leading to hyphal
morphogenesis; however, more-complicated mechanisms
cannot be
excluded.
Other phenotypes of pmt6 and pmt6 pmt1
mutants.
The heterozygous PMT6/pmt6 mutant CAP2-2 and
the homozygous pmt6 disruptant CAP2-234 showed the same
generation times in SD medium as the wild-type SC5314 or the
PMT6-reconstituted strain CAP2-2341(pCT34). Furthermore, the
homozygous pmt6/pmt6 mutant strains did not aggregate,
unlike the pmt1/pmt1 mutants (41), and grew as
regular yeast cells. On the other hand, doubly mutated strains lacking
both PMT6 and PMT1 (strain CPP117) essentially showed the phenotypes of pmt1 mutants, including slower
growth, aggregation, antifungal sensitivity, and complete loss of
hyphal morphogenesis on Spider medium (but retained the ability for
hyphal morphogenesis in serum media) (41); a few additional
sensitivities not present in strains containing single mutations were
also observed (see above).
To test if known secreted proteins are modified by Pmt6p, we compared
the electrophoretic mobilities in SDS-polyacrylamide
gel
electrophoresis of several known secreted proteins in
pmt6/pmt6 mutants and wild-type cells. Immunoblottings were
performed using
antibodies to Als1p (
19) Int1p
(
14), Cdr1p (
30), and Pma1p
(
27), as
described previously (
41). None of the tested proteins
showed a different electrophoretic migration in
pmt6/pmt6
mutants,
indicating that these proteins are not extensively modified by
Pmt6p. Furthermore, we did not observe any different activities
and
intra- or extracellular distributions of chitinase activities
in
pmt6 mutants compared to those in
PMT6 strains.
Different results
were obtained previously for
pmt1 mutants,
which showed altered
migration of Als1p and altered activities and
distributions of
chitinase (
41).
An analysis of the enzymatic Pmt activity was performed by an in vitro
assay measuring the transfer of [
14C]mannose residues
from Dol-P-[
14C]mannose to the acceptor peptide
acetyl-YATAV-NH
2 (
40-42). Wild-type
strain
SC5314 showed high levels of Pmt activity, while in the
homozygous
pmt1 mutants the enzymatic activity was decreased to
27% of
wild-type activity (Table
2). In a
homozygous
pmt1 pmt6 knockout mutant the Pmt activity was
nearly identical (26% compared
to that of the homozygous
pmt1 disruptant). Thus, Pmt6p is not
detectably active under
standard assay conditions and contributes
little to the overall Pmt
activity of cells. Interestingly, we
observed that in a strain with
only
PMT6 deleted Pmt activity
was increased, rising to
129% of wild-type activity (Table
2).
Possibly, in strains lacking
Pmt6p a compensatory increase in
activities of Pmt1p and/or other Pmt
proteins occurs.
Pmt6p is required for adherence and virulence of C. albicans.
Mannoproteins are necessary for adhesion of C. albicans to a number of surfaces (13). Recently we
demonstrated that PMT1 is required for adhesion of C. albicans to EC (41). To explore the role of Pmt6p in
C. albicans adhesion, we tested the ability of heterozygous
and homozygous pmt6 strains to adhere to PAEC. In comparison
to wild-type cells (strain SC5314), strains bearing disruptions in both
C. albicans PMT6 alleles adhered less to a monolayer of PAEC
(Table 3). While 35% of wild-type cells
and 35 to 39% of heterozygous PMT6/pmt6 mutants adhered to
the PAEC monolayer in 45 min, the adherence of homozygous
pmt6 disruptants CAP2-234 and CAP2-239 was reduced to 13 and
25%, respectively. Reintroduction of the PMT6 gene into one
pmt6/pmt6 mutant increased adherence, as expected.
To test whether Pmt6p influences the virulence of
C. albicans in a mouse model of systemic infection, 10
5
cells of the homozygous disruptant CAP2-239 and the reconstituted
strain CAP2-2391[pCT35] were injected into the tail vein of
immunocompetent
mice. The mice were observed for 30 days. The data of
Fig.
5 are
representative of a total of
four independent infections with
similar results. Mice infected with
the reconstituted wild-type
strain (
pmt6/pmt6
[
PMT6]) showed a mean survival time (MST) of
12 days (Fig.
5), while animals treated with the homozygous
pmt6-disrupted
strain survived significantly longer (MST, 22 days). Thus, we
could
prove that
PMT6 is involved in the virulence of
C. albicans.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 5.
Virulence of C. albicans strains. Strains
CAP2-239 ( ; pmt6/pmt6) and the
PMT6-reconstituted strain CAP2-2391(pCT35) ( ;
pmt6/pmt6 [PMT6]) were compared. The survival
of mice (n = 12) injected with 105 C. albicans cells in the tail vein was determined.
|
|
 |
DISCUSSION |
The C. albicans Pmt6 protein corresponds to one
subclass of Pmt proteins in S. cerevisiae comprising the
Pmt2, Pmt3, and Pmt6 proteins. We previously described the C. albicans Pmt1 protein, which corresponds to a second subclass
comprising the S. cerevisiae Pmt1 and Pmt5 proteins
(41). By nonstringent hybridization using S. cerevisiae PMT1 to PMT7 probes we only detected two
PMT genes in C. albicans DNA by Southern blotting
(41); these genes correspond to PMT1 and
PMT6, which are described here. In the C. albicans genome sequencing project
(http://www-sequence.stanford.edu/group/candida/), which at present
covers approximately 95% of the genome (S. Scherer, personal
communication), gene fragments designated PMT1 to
PMT5 have been discovered. Computer comparisons revealed
that the genes designated PMT1 and PMT5
correspond to the PMT1 sequence described by us
(41), while the gene fragments designated PMT2
and PMT3 are identical to PMT6, which is
described here. Recently, other gene fragments, named PMT4,
were identified by the C. albicans genome project;
PMT4 is different from PMT1 and PMT6.
Thus, the present evidence suggests that the set of PMT
genes in C. albicans comprises PMT1,
PMT4, and PMT6. The existence of only three
PMT genes in C. albicans differs from what is
found for S. cerevisiae, which harbors seven paralogous
PMT genes (38). Deletion of three or four of the
seven PMT genes is lethal in S. cerevisiae
(15), while we show here that in C. albicans two
of the three PMT genes can be deleted without a loss in
viability. This finding raises the intriguing question of whether
proteins other than Pmt proteins could mediate O glycosylation in fungi.
The structure of Pmt6p corresponds to that of the S. cerevisiae Pmt proteins, which presumably includes a
seven-transmembrane helical configuration in endoplasmic reticulum
membranes (39). Nevertheless, although Northern blotting
demonstrated that PMT6 is expressed (although at a lower
level than PMT1), no effect of PMT6 deletion on
in vitro Pmt enzymatic activity was observed. It is possible that the
standard acceptor peptide used in the enzymatic assay does not
correspond to the substrate specificity of Pmt6p or that assay
conditions able to detect Pmt1p activity fail to reveal Pmt6p. Several
of our findings support the hypothesis that Pmt6p does not have a
general role in O glycosylation but rather modifies and/or regulates a
relatively narrow set of target proteins. First, in vitro Pmt enzymatic
activities are identical in extracts of the wild-type and
pmt6 disruptants. Second, we did not observe altered
electrophoretic migrations of several secreted and cell wall proteins,
including Als1p, Int1p, Cdr1p, and Pma1p, as detected by
immunoblotting. The Als1 protein was of special interest because its
overproduction in S. cerevisiae induced adhesion to host
cells (12) and because the electrophoretic migration of
Als1p was altered in pmt1 mutants (41). Third, activity and intra- and extracellular distributions of chitinase were
not affected by deletion of PMT6, while these parameters were altered in pmt1 mutants (41). Fourth, the
generation of new phenotypes in pmt6 pmt1 double mutants
compared to that in pmt6 and pmt1 single mutants,
i.e., supersensitivity to the iron chelator EDDHA and to caffeine,
suggests that Pmt1p and Pmt6p proteins mannosylate an overlapping, but
different, set of target proteins. EDDHA sensitivity has not yet been
described in connection with alterations in the cell surface structure
of C. albicans. In S. cerevisiae some
combinations of pmt mutations are known to cause increased
sensitivities to caffeine (15).
An unexpected phenotype of C. albicans pmt mutants was their
inability to form hyphae in certain inducing conditions, although growth of the yeast form was unaffected. The pmt1 mutation
led to a complete block of morphogenesis, while the pmt6
mutant, although severely compromised, still formed short hyphal
extensions on solid Spider medium. Current models of dimorphism in
C. albicans comprise two parallel signaling pathways
consisting of a protein kinase (Cek1 MAP kinase or Tpk2 protein kinase
A [PKA]) and a transcription factor that are regulated by these
kinases (Cph1p or Efg1p) (23, 35, 36). We do not favor the
hypothesis that lack of O glycosylation led to defects in, e.g.,
structural components which are needed for hyphal formation, because
hyphae developed in both pmt1 and pmt6 mutants in
the presence of serum or GlcNAc. Instead, we speculate that
O-glycosylated components situated functionally upstream of the Cek1
MAP kinase and/or the Tpk2 PKA were compromised in pmt
mutants, since we could restore filamentation by overexpression of both
kinases and the associated transcription factors. Suppression of only
the morphogenetic phenotype, not the antifungal sensitivity phenotype,
of pmt6 strains was observed, indicating different functions
of Pmt6p in both processes. Hypothetical components upstream of
signaling pathways could, for example, be O-glycosylated sensor
proteins located in the cytoplasmic membrane that mediate external
signals. To our knowledge this is the first report describing
suppression of a specific glycosylation defect by an elevated level of
signaling components.
Much of the recent interest in C. albicans biology is due to
the need to develop new and effective antifungals. In this respect it
is of interest that C. albicans cells lacking Pmt6p were
supersensitive to hygromycin B, a phenotype that in S. cerevisiae emerges only if at least two pmt mutations
are combined or in mutants defective in N glycosylation (8).
Because sensitivities to other agents were not observed, it appears
that the pmt6 mutation causes less-drastic sensitivity
phenotypes than the pmt1 mutation. The molecular mechanisms by which O or N glycosylation modify sensitivity characteristics of
fungi in general and which contribute to the relatively high intrinsic
resistance of C. albicans to antifungals and other toxic agents remain to be established. The function of Pmt6p in antifungal resistance is not related to its function in morphogenesis, because overexpression of signaling components (see above) did not alter the
antifungal sensitivities of pmt6 mutants. Conceivably, agents lowering
levels of resistance to antifungals may be of great interest to
complement current antifungal therapies. Furthermore, fungal Pmt
proteins are potential selective targets for novel antifungals, because
the bulk of O glycosylation in mammals occurs via a biosynthetic pathway different from that in fungi. We have shown here that deletion
of pmt6 generates a significant drop in virulence in a
system model of mouse infection, while the pmt1 mutation
produces absolute avirulence (41). The reduced virulence
observed for pmt6 mutants is not caused by a general effect
on growth but may involve the block in morphogenesis as described above
and/or the defective adhesion to endothelial cells.
 |
ACKNOWLEDGMENTS |
Plasmid p99 was generously supplied by S. Scherer. We thank A. Goffeau, M. Hostetter, L. Hoyer, and D. Sanglard for contributing antisera. We thank A. Sonneborn for help with Northern blottings.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Mikrobiologie, Heinrich-Heine-Universität,
Universitätsstr. 1/26.12, D-40225 Düsseldorf, Germany.
Phone and fax: 49 (211)8115176. E-mail:
joachim.ernst{at}uni-duesseldorf.de.
 |
REFERENCES |
| 1.
|
Aramayo, R., and R. L. Metzenberg.
1996.
Meiotic transvection in fungi.
Cell
86:103-113[CrossRef][Medline].
|
| 2.
|
Bourdineaud, J.-P.,
J. M. van der Vaart,
M. Donzeau,
G. de Sampaio,
C. T. Verrips, and G. J.-M. Lauquin.
1998.
Pmt1 mannosyltransferase is involved in cell wall incorporation of several proteins in Saccharomyces cerevisiae.
Mol. Microbiol.
27:85-98[CrossRef][Medline].
|
| 3.
|
Buurman, E. T.,
C. Westwater,
B. Hube,
A. J. P. Brown,
F. C. Odds, and N. A. R. Gow.
1998.
Molecular analysis of CaMnt1p, a mannosyltransferase important for adhesion and virulence of Candida albicans.
Proc. Natl. Acad. Sci. USA
95:7670-7675[Abstract/Free Full Text].
|
| 4.
|
Cannon, R. D.,
H. F. Jenkinson, and M. G. Shepherd.
1992.
Cloning and expression of Candida albicans ADE2 and proteinase genes on a replicative plasmid in C. albicans and in Saccharomyces cerevisiae.
Mol. Gen. Genet.
235:453-457[CrossRef][Medline].
|
| 5.
|
Cassone, A.,
P. A. Sullivan, and M. G. Shepherd.
1985.
N-acetyl-D-glucosamine-induced morphogenesis in Candida albicans.
Microbiologica
8:85-99[Medline].
|
| 6.
|
Csank, C.,
C. Makris,
S. Meloche,
K. Schröppel,
M. Röllinghoff,
D. Dignard,
D. Y. Thomas, and M. Whiteway.
1997.
Derepressed hyphal growth and reduced virulence in a VH1 family-related protein phosphatase mutant of the human pathogen Candida albicans.
Mol. Biol. Cell
8:2539-2551[Abstract/Free Full Text].
|
| 7.
|
Csank, C.,
K. Schröppel,
E. Leberer,
D. Harcus,
O. Mohamed,
S. Meloche,
D. Y. Thomas, and M. Whiteway.
1998.
Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis.
Infect. Immun.
66:2713-2721[Abstract/Free Full Text].
|
| 8.
|
Dean, N.
1995.
Yeast glycosylation mutants are sensitive to aminoglycosides.
Proc. Natl. Acad. Sci. USA
92:1287-1291[Abstract/Free Full Text].
|
| 9.
|
Delbrück, S., and J. F. Ernst.
1993.
Morphogenesis-independent regulation of actin transcript levels in the pathogenic yeast Candida albicans.
Mol. Microbiol.
10:859-866[CrossRef][Medline].
|
| 10.
|
Finck, M.,
N. Bergmann,
B. Jansson, and J. F. Ernst.
1996.
Defective threonine-linked glycosylation of human insulin-like growth factor in mutants of the yeast Saccharomyces cerevisiae.
Glycobiology
6:313-320[Abstract/Free Full Text].
|
| 11.
|
Fonzi, W. A., and M. Y. Irwin.
1993.
Isogenic strain construction and gene mapping in Candida albicans.
Genetics
134:717-728[Abstract].
|
| 12.
|
Fu, Y.,
G. Rieg,
W. A. Fonzi,
P. H. Belanger,
J. E. Edwards, Jr., and S. G. Filler.
1998.
Expression of the Candida albicans gene ALS1 in Saccharomyces cerevisiae induces adherence to endothelial and epithelial cells.
Infect. Immun.
66:1783-1786[Abstract/Free Full Text].
|
| 13.
|
Fukazawa, Y., and K. Kagaya.
1997.
Molecular bases of adhesion of Candida albicans.
J. Med. Vet. Mycol.
35:87-99[Medline].
|
| 14.
|
Gale, C. A.,
C. M. Bendel,
M. McClellan,
M. Hauser,
J. M. Becker,
J. Berman, and M. K. Hostetter.
1998.
Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1.
Science
279:1355-1358[Abstract/Free Full Text].
|
| 15.
|
Gentzsch, M., and W. Tanner.
1996.
The PMT gene family: protein O-glycosylation in Saccharomyces cerevisiae is vital.
EMBO J.
15:5752-5759[Medline].
|
| 16.
|
Gentzsch, M., and W. Tanner.
1997.
Protein-O-glycosylation in yeast: protein-specific mannosyltransferases.
Glycobiology
7:481-486[Abstract/Free Full Text].
|
| 17.
|
Gow, N. A. R.,
P. W. Robbins,
J. W. Lester,
A. J. Brown,
W. A. Fonzi,
T. Chapman, and O. S. Kinsman.
1994.
A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans.
Proc. Natl. Acad. Sci. USA
91:6216-6220[Abstract/Free Full Text].
|
| 18.
|
Holmes, A. R., and M. G. Shepherd.
1988.
Nutritional factors determine germ tube formation in Candida albicans.
J. Med. Vet. Mycol.
26:127-131[Medline].
|
| 19.
|
Hoyer, L. L.,
J. Clevenger,
J. E. Hecht,
E. J. Ehrhart, and F. M. Poulet.
1999.
Detection of Als proteins on the cell wall of Candida albicans in murine tissues.
Infect. Immun.
67:4251-4255[Abstract/Free Full Text].
|
| 20.
|
Immervoll, T.,
M. Gentzsch, and W. Tanner.
1995.
PMT3 and PMT4, two new members of the protein-O-mannosyltransferase gene family of Saccharomyces cerevisiae.
Yeast
11:1345-1351[CrossRef][Medline].
|
| 21.
|
Jurado, L. A.,
A. Coloma, and J. Cruces.
1999.
Identification of a human homolog of the drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyltransferase, and assignment to human chromosome 9q34.1.
Genomics
58:171-180[CrossRef][Medline].
|
| 22.
|
Liu, H.,
J. R. Köhler, and G. R. Fink.
1994.
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog.
Science
266:1723-1726[Abstract/Free Full Text].
|
| 23.
|
Lo, H.-J.,
J. R. Köhler,
B. Didomenico,
D. Loebenberg,
A. Cacciapuoti, and G. R. Fink.
1997.
Nonfilamentous C. albicans mutants are avirulent.
Cell
90:939-949[CrossRef][Medline].
|
| 24.
|
Lussier, M.,
M. Gentzsch,
A.-M. Sdicu,
H. Bussey, and W. Tanner.
1995.
Protein O-glycosylation in yeast: the PMT2 gene specifies a second protein O-mannosyltransferase that functions in addition to the PMT1-encoded activity.
J. Biol. Chem.
270:2770-2775[Abstract/Free Full Text].
|
| 25.
|
Martín-Blanco, E., and A. García-Bellido.
1996.
Mutations in the rotated abdomen locus affect muscle development and reveal intrinsic asymmetry in Drosophila.
Proc. Natl. Acad. Sci. USA
93:6048-6052[Abstract/Free Full Text].
|
| 26.
|
McCusker, J. H., and R. W. Davis.
1991.
The use of proline as a nitrogen source causes hypersensitivity to, and allows more economical use of 5-FOA in Saccharomyces cerevisiae.
Yeast
7:607-608[CrossRef][Medline].
|
| 27.
|
Monk, B. C.,
M. B. Kurtz,
J. A. Marrinan, and D. S. Perlin.
1991.
Cloning and characterization of the plasma membrane H+-ATPase from Candida albicans.
J. Bacteriol.
173:6826-6836[Abstract/Free Full Text].
|
| 28.
|
Mrsa, V.,
T. Seidl,
M. Gentzsch, and W. Tanner.
1997.
Specific labelling of cell wall proteins by biotinylation. Identification of four covalently linked O-mannosylated proteins of Saccharomyces cerevisiae.
Yeast
13:1145-1154[CrossRef][Medline].
|
| 29.
|
Sanders, S. L.,
M. Gentzsch,
W. Tanner, and I. Herskowitz.
1999.
O-glycosylation of Axl2/Bud10p by Pmt4p is required for its stability, localization, and function in daughter cells.
J. Cell Biol.
145:1177-1188[Abstract/Free Full Text].
|
| 30.
|
Sanglard, D.,
K. Kuchler,
F. Ischer,
J. L. Pagani,
M. Monod, and J. Bille.
1995.
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Antimicrob. Agents Chemother.
39:2378-2386[Abstract].
|
| 31.
|
Santos, M. A. S., and M. F. Tuite.
1995.
The CUG codon is decoded in vivo as serine and not leucine in Candida albicans.
Nucleic Acids Res.
23:1481-1486[Abstract/Free Full Text].
|
| 32.
|
Scherer, S., and P. T. Magee.
1990.
Genetics of Candida albicans.
Microbiol. Rev.
54:226-241[Abstract/Free Full Text].
|
| 33.
|
Schmitt, M. E.,
T. A. Brown, and B. L. Trumpower.
1990.
A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae.
Nucleic Acids Res.
18:3091[Free Full Text].
|
| 34.
|
Sherman, F.,
G. R. Fink, and J. B. Hicks.
1986.
Methods in yeast genetics.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 35.
|
Sonneborn, A.,
D. P. Bockmühl,
M. Gerads,
K. Kurpanek,
D. Sanglard, and J. F. Ernst.
2000.
Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans.
Mol. Microbiol.
35:386-396[CrossRef][Medline].
|
| 36.
|
Stoldt, V. R.,
A. Sonneborn,
C. E. Leuker, and J. F. Ernst.
1997.
Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi.
EMBO J.
16:1982-1991[CrossRef][Medline].
|
| 37.
|
Strahl-Bolsinger, S.,
T. Immervoll,
R. Deutzmann, and W. Tanner.
1993.
PMT1, the gene for a key enzyme of protein O-glycosylation in Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
90:8164-8168[Abstract/Free Full Text].
|
| 38.
|
Strahl-Bolsinger, S.,
M. Gentzsch, and W. Tanner.
1999.
Protein O-mannosylation.
Biochim. Biophys. Acta
1426:297-307[Medline].
|
| 39.
|
Strahl-Bolsinger, S., and A. Scheinost.
1999.
Transmembrane topology of Pmt1p, a member of an evolutionarily conserved family of protein O-mannosyltransferases.
J. Biol. Chem.
274:9068-9075[Abstract/Free Full Text].
|
| 40.
|
Strahl-Bolsinger, S., and W. Tanner.
1991.
Protein O-glycosylation in Saccharomyces cerevisiae. Purification and characterization of the dolichyl-phosphate-D-mannose-protein O-D-mannosyltransferase.
Eur. J. Biochem.
196:185-190[Medline].
|
| 41.
|
Timpel, C.,
S. Strahl-Bolsinger,
K. Ziegelbauer, and J. F. Ernst.
1998.
Multiple functions of Pmt1p-mediated protein O-mannosylation in the fungal pathogen Candida albicans.
J. Biol. Chem.
273:20837-20846[Abstract/Free Full Text].
|
| 42.
|
Weston, A.,
P. M. Nassau,
C. Henly, and M. S. Marriott.
1993.
Protein O-mannosylation in Candida albicans. Determination of the amino acid sequences of peptide acceptors for protein O-mannosyltransferase.
Eur. J. Biochem.
215:845-849[Medline].
|
| 43.
|
Zink, S.,
T. Naß,
P. Rösen, and J. F. Ernst.
1996.
Migration of the fungal pathogen Candida albicans across endothelial monolayers.
Infect. Immun.
64:5085-5091[Abstract].
|
Journal of Bacteriology, June 2000, p. 3063-3071, Vol. 182, No. 11
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lommel, M., Strahl, S.
(2009). Protein O-mannosylation: Conserved from bacteria to humans. Glycobiology
19: 816-828
[Abstract]
[Full Text]
-
Mora-Montes, H. M., Bates, S., Netea, M. G., Diaz-Jimenez, D. F., Lopez-Romero, E., Zinker, S., Ponce-Noyola, P., Kullberg, B. J., Brown, A. J. P., Odds, F. C., Flores-Carreon, A., Gow, N. A. R.
(2007). Endoplasmic Reticulum {alpha}-Glycosidases of Candida albicans Are Required for N Glycosylation, Cell Wall Integrity, and Normal Host-Fungus Interaction. Eukaryot Cell
6: 2184-2193
[Abstract]
[Full Text]
-
Olson, G. M., Fox, D. S., Wang, P., Alspaugh, J. A., Buchanan, K. L.
(2007). Role of Protein O-Mannosyltransferase Pmt4 in the Morphogenesis and Virulence of Cryptococcus neoformans. Eukaryot Cell
6: 222-234
[Abstract]
[Full Text]
-
Peltroche-Llacsahuanga, H., Goyard, S., d'Enfert, C., Prill, S. K.-H., Ernst, J. F.
(2006). Protein O-Mannosyltransferase Isoforms Regulate Biofilm Formation in Candida albicans.. Antimicrob. Agents Chemother.
50: 3488-3491
[Abstract]
[Full Text]
-
Bai, C., Xu, X.-L., Chan, F.-Y., Lee, R. T. H., Wang, Y.
(2006). MNN5 Encodes an Iron-Regulated {alpha}-1,2-Mannosyltransferase Important for Protein Glycosylation, Cell Wall Integrity, Morphogenesis, and Virulence in Candida albicans. Eukaryot Cell
5: 238-247
[Abstract]
[Full Text]
-
Bates, S., Hughes, H. B., Munro, C. A., Thomas, W. P. H., MacCallum, D. M., Bertram, G., Atrih, A., Ferguson, M. A. J., Brown, A. J. P., Odds, F. C., Gow, N. A. R.
(2006). Outer Chain N-Glycans Are Required for Cell Wall Integrity and Virulence of Candida albicans. J. Biol. Chem.
281: 90-98
[Abstract]
[Full Text]
-
Prasad, T., Saini, P., Gaur, N. A., Vishwakarma, R. A., Khan, L. A., Haq, Q. M. R., Prasad, R.
(2005). Functional Analysis of CaIPT1, a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans. Antimicrob. Agents Chemother.
49: 3442-3452
[Abstract]
[Full Text]
-
Rouabhia, M., Schaller, M., Corbucci, C., Vecchiarelli, A., Prill, S. K.-H., Giasson, L., Ernst, J. F.
(2005). Virulence of the Fungal Pathogen Candida albicans Requires the Five Isoforms of Protein Mannosyltransferases. Infect. Immun.
73: 4571-4580
[Abstract]
[Full Text]
-
Bates, S., MacCallum, D. M., Bertram, G., Munro, C. A., Hughes, H. B., Buurman, E. T., Brown, A. J. P., Odds, F. C., Gow, N. A. R.
(2005). Candida albicans Pmr1p, a Secretory Pathway P-type Ca2+/Mn2+-ATPase, Is Required for Glycosylation and Virulence. J. Biol. Chem.
280: 23408-23415
[Abstract]
[Full Text]
-
Munro, C. A., Bates, S., Buurman, E. T., Hughes, H. B., MacCallum, D. M., Bertram, G., Atrih, A., Ferguson, M. A. J., Bain, J. M., Brand, A., Hamilton, S., Westwater, C., Thomson, L. M., Brown, A. J. P., Odds, F. C., Gow, N. A. R.
(2005). Mnt1p and Mnt2p of Candida albicans Are Partially Redundant {alpha}-1,2-Mannosyltransferases That Participate in O-Linked Mannosylation and Are Required for Adhesion and Virulence. J. Biol. Chem.
280: 1051-1060
[Abstract]
[Full Text]
-
Herrero, A. B., Magnelli, P., Mansour, M. K., Levitz, S. M., Bussey, H., Abeijon, C.
(2004). KRE5 Gene Null Mutant Strains of Candida albicans Are Avirulent and Have Altered Cell Wall Composition and Hypha Formation Properties. Eukaryot Cell
3: 1423-1432
[Abstract]
[Full Text]
-
Rowbottom, L., Munro, C. A., Gow, N. A. R.
(2004). Candida albicans mutants in the BNI4 gene have reduced cell-wall chitin and alterations in morphogenesis. Microbiology
150: 3243-3252
[Abstract]
[Full Text]
-
Weber, Y., Prill, S. K.-H., Ernst, J. F.
(2004). Pmt-Mediated O Mannosylation Stabilizes an Essential Component of the Secretory Apparatus, Sec20p, in Candida albicans. Eukaryot Cell
3: 1164-1168
[Abstract]
[Full Text]
-
Hobson, R. P., Munro, C. A., Bates, S., MacCallum, D. M., Cutler, J. E., Heinsbroek, S. E. M., Brown, G. D., Odds, F. C., Gow, N. A.R.
(2004). Loss of Cell Wall Mannosylphosphate in Candida albicans Does Not Influence Macrophage Recognition. J. Biol. Chem.
279: 39628-39635
[Abstract]
[Full Text]
-
Galan, A., Casanova, M., Murgui, A., MacCallum, D. M., Odds, F. C., Gow, N. A. R., Martinez, J. P.
(2004). The Candida albicans pH-regulated KER1 gene encodes a lysine/glutamic-acid-rich plasma-membrane protein that is involved in cell aggregation. Microbiology
150: 2641-2651
[Abstract]
[Full Text]
-
Oka, T., Hamaguchi, T., Sameshima, Y., Goto, M., Furukawa, K.
(2004). Molecular characterization of protein O-mannosyltransferase and its involvement in cell-wall synthesis in Aspergillus nidulans. Microbiology
150: 1973-1982
[Abstract]
[Full Text]
-
Sanchez, A. A., Johnston, D. A., Myers, C., Edwards, J. E. Jr., Mitchell, A. P., Filler, S. G.
(2004). Relationship between Candida albicans Virulence during Experimental Hematogenously Disseminated Infection and Endothelial Cell Damage In Vitro. Infect. Immun.
72: 598-601
[Abstract]
[Full Text]
-
Girrbach, V., Strahl, S.
(2003). Members of the Evolutionarily Conserved PMT Family of Protein O-Mannosyltransferases Form Distinct Protein Complexes among Themselves. J. Biol. Chem.
278: 12554-12562
[Abstract]
[Full Text]
-
Dunyak, D. S., Everdeen, D. S., Albanese, J. G., Quinn, C. L.
(2002). Deletion of Individual mRNA Capping Genes Is Unexpectedly Not Lethal to Candida albicans and Results in Modified mRNA Cap Structures. Eukaryot Cell
1: 1010-1020
[Abstract]
[Full Text]
-
Willer, T., Amselgruber, W., Deutzmann, R., Strahl, S.
(2002). Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology
12: 771-783
[Abstract]
[Full Text]
-
Herrero, A. B., Uccelletti, D., Hirschberg, C. B., Dominguez, A., Abeijon, C.
(2002). The Golgi GDPase of the Fungal Pathogen Candida albicans Affects Morphogenesis, Glycosylation, and Cell Wall Properties. Eukaryot Cell
1: 420-431
[Abstract]
[Full Text]
-
Nishikawa, A., Poster, J. B., Jigami, Y., Dean, N.
(2002). Molecular and Phenotypic Analysis of CaVRG4, Encoding an Essential Golgi Apparatus GDP-Mannose Transporter. J. Bacteriol.
184: 29-42
[Abstract]
[Full Text]
-
Weber, Y., Santore, U. J., Ernst, J. F., Swoboda, R. K.
(2001). Divergence of Eukaryotic Secretory Components: the Candida albicans Homolog of the Saccharomyces cerevisiae Sec20 Protein Is N Terminally Truncated, and Its Levels Determine Antifungal Drug Resistance and Growth. J. Bacteriol.
183: 46-54
[Abstract]
[Full Text]